EUVIMEDEUVIMED entdecken
Crossref

Survival rate of patients undergoing aortic, mitral, and tricuspid valve replacement with prosthetic valves

Elahe Zare, Mohammad Hossein Soltani, Maryam Chenaghlou, Mehdi Hadadzadeh, Mehrdad Mansouri, Rezvanieh Salehi, Razieh Parizad

Cardiovascular Biomedicine Journal · 2021

DOI: 10.18502/cbj.v1i1.7550 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Biomedicine Journal, 2021. Verfasst von Elahe Zare und 6 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The burden of valvular heart disease (VHD) is high and increasing all around the world due to aging of the population. The etiologic factors of VHD are different among countries. There is little data about etiologic factors of VHD in Iran. The aim of present study was to determine the associated factors related to the 5-year survival and mortality rate of patients undergoing bileaflet mechanical valve replacement.

Methods

In this retrospective cohort study, demographic, electrocardiographic and echocardiographic data of patients who had underwent aortic, mitral and tricuspid valve replacement with bileaflet valves in the Afshar Hospital in Yazd, Iran, between March 2008 to February 2015 were obtained from their records. Supplementary information like hemorrhagic or thromboembolic events, rehospitalization and death during follow-up were gathered through contact with patients. For analysis of the data, SPSS ver. 19 was used.

Results

Four hundred and thirty eight patients entered the study. Male gender was slightly predominant (%53). Mean age of the patients was 51.6 ± 17.4 years. The rate of in-hospital mortality was 9.8% while the 5-year survival rate was 82.42%. The rate of major thromboembolic events was 0.97%/year and that of major hemorrhagic events was 0.5%/year. Patients with older age, lower cardiac ejection fraction (less than 30%) and with atrial fibrillation had a higher rate of mortality (P = 0.001). In-hospital mortalities were 3%, 9%, 12% and 15% for AVR, AVR+MVR, MVR and CABG+valvular surgery, respectively.

Conclusions

Higher rate of mitral valve surgery in this study may be due to possible predominance of rheumatic valvular pathology similar to other developing countries. Rate of 5-year survival, thromboembolic and hemorrhagic rates were acceptable and comparable to global reports.

Zitieren

APA

Zare, E., Soltani, M. H., Chenaghlou, M., Hadadzadeh, M., Mansouri, M., Salehi, R., & Parizad, R. (2021). Survival rate of patients undergoing aortic, mitral, and tricuspid valve replacement with prosthetic valves. Cardiovascular Biomedicine Journal. https://doi.org/10.18502/cbj.v1i1.7550

Vancouver

Zare E, Soltani MH, Chenaghlou M, Hadadzadeh M, Mansouri M, Salehi R, et al. Survival rate of patients undergoing aortic, mitral, and tricuspid valve replacement with prosthetic valves. Cardiovascular Biomedicine Journal. 2021. doi:10.18502/cbj.v1i1.7550

BibTeX
@article{Zare2021,
  author = {Zare, Elahe and Soltani, Mohammad Hossein and Chenaghlou, Maryam and Hadadzadeh, Mehdi and Mansouri, Mehrdad and Salehi, Rezvanieh and Parizad, Razieh},
  title = {Survival rate of patients undergoing aortic, mitral, and tricuspid valve replacement with prosthetic valves},
  journal = {Cardiovascular Biomedicine Journal},
  year = {2021},
  doi = {10.18502/cbj.v1i1.7550}
}
Kostenlos starten →